Omalizumab improves perceived stress, anxiety, and depression in chronic spontaneous urticaria

J Allergy Clin Immunol Pract. 2021 Mar;9(3):1402-1404. doi: 10.1016/j.jaip.2020.11.026. Epub 2020 Nov 26.
No abstract available

MeSH terms

  • Anti-Allergic Agents* / therapeutic use
  • Anxiety / drug therapy
  • Chronic Disease
  • Chronic Urticaria*
  • Depression / drug therapy
  • Humans
  • Omalizumab / therapeutic use
  • Stress, Psychological
  • Treatment Outcome
  • Urticaria* / drug therapy

Substances

  • Anti-Allergic Agents
  • Omalizumab